Skip to Content

Tag: Diabetes Testing

Specialty Providers

Abbott Labs, Alere deal moves forward

April 18, 2017HME News Staff

ABBOTT PARK, Ill., and WALTHAM, Mass. - Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.Under amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of approximately $5.3 billion, reduced from $5.8 billion, according to a press release.Abbott first announced plans to buy Alere in February 2016. Later that year, however, Abbott filed a complaint in the Delaware Court of Chancery, asking a judge to terminate...

Abbott, Alere, Arriva Medical, Diabetes Testing, M&A

Read Full Articlered right arrow icon